1-8 of 8
P Mueller
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clonal Dynamics of Leukemic and Clonal Hematopoiesis Mutations Predict Relapse in Single Cell MRD Analysis of AML in First Complete Remission

Enise Ceran, Anne Kathrin Merbach, Christian Rohde, Robert Durruthy-Durruthy, Adam Sciambi, Michelle Lotze, Gema Fuerte, Matteo Cattaneo, Ivan Lukic, Maxi Wass, Judith Schaffrath, Christoph Röllig, Richard F. Schlenk, Marina Scheller, Simone Kowoll, Jörg Steighardt, Bayram Edemir, Beatrice Ludwig-Kraus, Lutz P. Mueller, Sabine Edemir, Abi Vainstein-Haras, Ella Sorani, Irit Gliko Kabir, Shaul Kadosh, Cora Gromann, Andreas Wienke, Claudia Wickenhauser, Claudia D Baldus, Uwe Platzbecker, Hubert Serve, Martin Bornhäuser, Carsten Müller-Tidow
Journal: Blood
Blood (2024) 144 (Supplement 1): 4337.
https://doi.org/10.1182/blood-2024-209953
Published: 2024
Journal Articles

KIR Haplotype B Donors but Not KIR-Ligand Mismatch Result in a Reduced Risk of Relapse After Haploidentical Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning and a CD3/CD19 Depleted Graft.

Sebastian Michaelis, cand.med., Markus Mezger, PhD, Martin Bornhauser, MD, Rudolf Trenschel, Gernot Stuhler, MD, Matthias Stelljes, MD, Lutz P Mueller, MD, Herrad Baurmann, MD, Birgit Federmann, MD, Lena Oevermann, MD, Lothar Kanz, MD, Rupert Handgretinger, MD, Wolfgang A. Bethge, MD
Journal: Blood
Blood (2012) 120 (21): 3101.
https://doi.org/10.1182/blood.V120.21.3101.3101
Published: 2012
Journal Articles

Using Platelet Proteomics as a Marker of Cardiac Failure in a Pacing-Induced Pig Heart Failure Model

Stephen W. Rothwell, PhD, Mark C. Haigney, Shao-kui Wi, Madelaine Clark, Ofer Eidelman, Catherine Jozwik, Meera Srivastava, Gregory P. Mueller, Matie Shou, Harvey B. Pollard
Journal: Blood
Blood (2008) 112 (11): 4535.
https://doi.org/10.1182/blood.V112.11.4535.4535
Published: 2008
Journal Articles

Prognostic Factors and Treatment Outcome in Lymphocyte Predominant and Classical Hodgkin’s Lymphoma: A Comprehensive Analysis of the German Hodgkin Study Group.

Lucia Nogova, MD, Thorsten Reineke, Corinne Brillant, Thomas Ruediger, Prof, Hans K. Mueller-Hermelink, Prof., Henning Bredenfeld, MD, Andreas Josting, MD, Rolf P. Mueller, Prof., Volker Diehl, Prof., Andreas Engert, Prof.
Journal: Blood
Blood (2006) 108 (11): 97.
https://doi.org/10.1182/blood.V108.11.97.97
Published: 2006
Journal Articles

Combined Modality Treatment of Two or Four Cycles of ABVD Followed by Involved Field Radiotherapy in the Treatment of Patients with Early Stage Hodgkin’s Lymphoma: Update Interim Analysis of the Randomised HD10 Study of the German Hodgkin Study Group (GHSG).

Andreas Engert, Annette Pluetschow, Hans T. Eich, Richard Herrmann, Bernd Doerken, Lothar Kanz, Richard Greil, Jana Markova, Beate Pfistner, Andreas Josting, Konrad Mueller-Hermelink, Ralf P. Mueller, Volker Diehl
Journal: Blood
Blood (2005) 106 (11): 2673.
https://doi.org/10.1182/blood.V106.11.2673.2673
Published: 2005
Journal Articles

Reduction of Combined Modality Treatment Intensity in Early Stage Hodgkin’s Lymphoma: Interim Analysis of the HD 10 Trial of the GHSG.

Volker Diehl, C. Brillant, A. Engert, J. Wolf, L. Nogova, R.-P. Mueller, H. Eich, H.K. Mueller-Hermelink, R. Herrmann, B. Doerken, L. Kanz, R. Greil, B. Pfistner, for the German Hodgkin′s lymphoma study group (GHSG), the Competence Network Malignant Lymphoma.
Journal: Blood
Blood (2004) 104 (11): 1307.
https://doi.org/10.1182/blood.V104.11.1307.1307
Published: 2004
Journal Articles

Intensification of Chemotherapy and Concomitant Reduction of Radiotherapy Dose in Intermediate Stage Hodgkin′s Lymphoma: Results of the Fourth Interim Analysis of the HD 11 Trial of the GHSG.

Volker Diehl, C. Brillant, A. Engert, J. Wolf, L. Nogova, R.-P. Mueller, H. Eich, H.K. Mueller Hermelink, R. Herrman, J. Markova, A. Ho, W. Hiddemann, B. Doerken, R. Greil, B. Pfistner, for the German Hodgkin′s Lymphoma Study Group (GHSG), the Competence Network Malignant Lymphoma.
Journal: Blood
Blood (2004) 104 (11): 1308.
https://doi.org/10.1182/blood.V104.11.1308.1308
Published: 2004
Journal Articles

Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas [see comments]

HH Gerhartz, M Engelhard, P Meusers, G Brittinger, W Wilmanns, G Schlimok, P Mueller, D Huhn, R Musch, W Siegert
Journal: Blood
Blood (1993) 82 (8): 2329–2339.
https://doi.org/10.1182/blood.V82.8.2329.2329
Published: 1993